(Q51813678)
Statements
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. (English)
1 reference
G Senti
1 reference
P Johansen
1 reference
S Haug
1 reference
C Bull
1 reference
C Gottschaller
1 reference
P Müller
1 reference
T Pfister
1 reference
P Maurer
1 reference
M F Bachmann
1 reference
N Graf
1 reference
T M Kündig
1 reference
16 February 2009
1 reference
39
1 reference
4
1 reference
562-570
1 reference
Identifiers
1 reference